Abstract
Purpose: The aim of this study was to identify positive predictors for survival in uveal melanoma (UM) patients treated with percutaneous hepatic perfusion with melphalan (M-PHP), by retrospectively pooling data from three centers. Materials and Methods: Retrospective analysis including patients (≥ 18 years) treated with M-PHP between February 2014 and December
... read more